|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received June 2, 2006
Revised July 4, 2006
Accepted after revision July 5, 2006
subunits in function of human
4-containing nicotinic receptors
1 Barrow Neurological Institute
2 Chandler-Gilbert Community College
3 University of Arizona
* To whom correspondence should be addressed. E-mail: jwu2{at}chw.edu.
Naturally-expressed nicotinic acetylcholine receptors (nAChR) containing
4 subunits (
4*-nAChR) in combination with
2 subunits (
4
2-nAChR) are among the most abundant, high-affinity nicotine binding sites in the mammalian brain.
4 subunits are also richly expressed and co-localize with
4-nAChR subunits in several brain regions implicated in behavioral responses to nicotine and nicotine dependence. Thus,
4
4-nAChR also may exist and play important functional roles. In this study, properties were determined of human
4
2- and
4
4-nAChR heterologously expressed de novo in human SH-EP1 epithelial cells. Whole-cell currents mediated via human
4
4-nAChR have ~4-fold higher amplitude than those mediated via human
4
2-nAChR and exhibit much slower acute desensitization and functional rundown. Nicotinic agonists induce peak whole-cell current responses typically with higher functional potency at
4
4-nAChR than at
4
2-nAChR. Cytisine and lobeline serve as full agonists at
4
4-nAChR but are only partial agonists at
4
2-nAChR. However, nicotinic antagonists, except hexamethonium, have comparable affinities for functional
4
2- and
4
4-nAChR. Whole-cell current responses show stronger inward rectification for
4
2-nAChR than for
4
4-nAChR at a positive holding potential. Collectively, these findings demonstrate that human nAChR
2 or
4 subunits can combine with a4 subunits to generate two forms of
4*-nAChR with distinctive physiological and pharmacological features. Diversity in
4*-nAChR is of potential relevance to nervous system function, disease, and nicotine dependence.
This article has been cited by other articles:
![]() |
L. C. Gahring, A. V. Osborne-Hereford, G. A. Vasquez-Opazo, and S. W. Rogers Tumor Necrosis Factor {alpha} Enhances Nicotinic Receptor Up-regulation via a p38MAPK-dependent Pathway J. Biol. Chem., January 11, 2008; 283(2): 693 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Salminen, J. A. Drapeau, J. M. McIntosh, A. C. Collins, M. J. Marks, and S. R. Grady Pharmacology of {alpha}-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice Mol. Pharmacol., June 1, 2007; 71(6): 1563 - 1571. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |